Source link : https://newshealth.biz/health-news/company-files-for-approval-of-new-pustular-psoriasis-rx/

Imsidolimab is a monoclonal antibody that inhibits interleukin-36 receptor signaling and is administered intravenously. Medscape Medical News Source link : https://www.medscape.com/viewarticle/company-files-approval-biologic-treating-generalized-2026a100060x?src=rss Author : Publish date : 2026-02-26 04:29:00 Copyright for syndicated content belongs to the linked Source.

The post Company Files for Approval of New Pustular Psoriasis Rx first appeared on News Health.

—-

Author : News Health

Publish date : 2026-02-26 04:29:00

Copyright for syndicated content belongs to the linked Source.

—-

12345678

Exit mobile version